Herbert Irving Comprehensive Cancer Center

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (May 2017) (Learn how and when to remove this template message) This article relies too much on references to primary sources. Please improve this by adding secondary or tertiary sources. (May 2017) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Herbert Irving Comprehensive Cancer Center (HICCC) is a National Cancer Institute NCI-designated Cancer Center, founded in 1911 at Columbia University Medical Center and part of the New York–Presbyterian Hospital Complex. The HICCC has more than 250 faculty members, 12 core facilities, and eight research programs within three divisions.^[1]

Research[]

There are eight research programs at HICCC divided into three divisions. The basic research division includes programs in cancer regulatory networks and cancer genetics and epigenetics. Programs in the disease-specific division focus on breast cancer, hematological cancer, prostate cancer, and neuro-oncology. The population science division includes cancer epidemiology and prevention, control, and disparities.

The center is currently receiving over $33 million in funding from the National Institutes of Health.^[2]

Patient Care[]

Patients are treated at NewYork-Presbyterian Hospital. HICCC physicians treat more than 3,500 patients annually. There are over 200 clinical trials available to patients.^[3]

History[]

HICCC first opened in 1911 as the Institute for Cancer Research and received its NCI designation in 1972, being promoted to comprehensive status in 1979. HICCC was previously led by Stephen G. Emerson, and the current interim director is Cory Abate-Shen, with Gary Schwartz as the deputy directory.^[4]

Notable faculty[]

• Stephen G. Emerson – director of the institute, researches stem cells transplants
• I. Bernard Weinstein – professor of genetics and public health, credited with developing the field of molecular epidemiology
• Siddhartha Mukherjee – professor of medicine, Pulitzer Prize-winning author, researches hematopoietic stem cells

References[]

External links[]

• Official website

Coordinates: 40°50′27″N 73°56′36″W / 40.84090°N 73.94330°W / 40.84090; -73.94330